pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    GC-1134A
    Fabry Disease GC Biopharma Corp
  • Phase 2
    GCC-4001
    Idiopathic Inflammatory Myopathy (IIM)$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GD2-SADA-177Lu-Proteus
    Melanoma Y-mAbs Therapeutics Inc
  • Phase 2
← prev
page 13 of 53
next →
131
Pain89
Neurology1
GEOCM-04S1
Coronavirus Disease 2019 (COVID-19)
$GOVX GeoVax Labs, Inc.
  • Phase 2
    GFH-375
    Colorectal Cancer$VSTM Verastem, Inc.
  • Phase 2
    GI-102
    Metastatic Melanoma GI Innovation Co Ltd
  • Phase 2
    GIM-122
    Solid Tumor Georgiamune Inc
  • Phase 2
    GIM-531
    Metastatic Melanoma Georgiamune Inc
  • Phase 2
    GLIX-1
    High-Grade Glioma Tetragon Biosciences Ltd
  • Phase 2
    GLK-221
    Keratoconus$GKOS GLAUKOS Corp
  • Phase 2
    GLK-302
    pilocarpine
    Presbyopia$GKOS GLAUKOS Corp
  • Phase 2
    GLK-321
    Demodex Blepharitis$GKOS GLAUKOS Corp
  • Phase 2
    GLK-401
    Age Related Macular Degeneration$GKOS GLAUKOS Corp
  • Phase 2
    GLY-200
    Type 2 Diabetes Glyscend Inc
  • Phase 2
    GNT-0003
    Crigler-Najjar Syndrome Genethon SA
  • Phase 2
    GO-2032c
    Refractory Acute Myeloid Leukemia Genus Oncology LLC
  • Phase 2
    GP-531
    Congestive Heart Failure (Heart Failure) ViCardia Therapeutics Inc
  • Phase 2
    GRC-54276
    Bile Duct Cancer (Cholangiocarcinoma) Ichnos Glenmark Innovation
  • Phase 2
    GRF-312
    Keratoconjunctivitis Sicca (Dry Eye)$GRFS Grifols SA
  • Phase 2
    GS-030
    Retinitis Pigmentosa (Retinitis) GenSight Biologics SA
  • Phase 2
    GSK-101
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance…$GSK GSK plc
  • Phase 2
    GSK-4382276A
    Seasonal Influenza$GSK GSK plc
  • Phase 2
    GSK-5536522
    Influenza A Virus, H5N1 Subtype Infections$GSK GSK plc
  • Phase 2
    GV-200251
    Cervical Cancer GV20 Therapeutics LLC
  • Phase 2
    Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
    Severe Combined Immune Deficiency (SCID) University of California San Francisco
  • Phase 2
    Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
    X-Linked SCID Boston Children's Hospital
  • Phase 2
    Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
    Retinal Degeneration National Eye Institute
  • Phase 2
    H-002
    Non-Small Cell Lung Cancer RedCloud Bio Inc
  • Phase 2
    H-1337
    Open-Angle Glaucoma D. Western Therapeutics Institute Inc
  • Phase 2
    HB-adMSC Allogeneic
    Crohn's Disease (Regional Enteritis) Hope Biosciences LLC